photo

Somponpun, Suwit Jack PhD

Pilot Project PI
Emerging Investigator - Cardiovascular Health
Assistant Professor
Dept. of Anatomy, Biochemistry & Physiology
John A. Burns School of Medicine

808.692.1420
suwit@hawaii.edu




Research Overview

2010-2011 RMATRIX Collaboration Pilot Projects Program Awards

(Co-funded in Partnership with the RTRN Small Grant Awards Program)

Project Description

Title: Morphogenetic Mechanism of Embryonic six2 in Establishing Nephron Endowment
Principal Investigator: Suwit Jack Somponpun, PhD, Dept. of Anatomy, Biochemistry & Physiology, UH JABSOM
Collaborator: Susanne Nicholas, MD, PhD, Dept. of Medicine, Charles Drew University
RMATRIX HEALTH Initiative(s): Cardiovascular
RMATRIX Funding: $25,000
External Link: http://www3.jabsom.hawaii.edu/Grad_DRB/faculty/somponpun.html

Abstract

Morphogenetic Mechanism of Embryonic six2 in Establishing Nephron Endowment

Suboptimal kidney development resulting in an in-born deficit in nephron number can have lifelong consequences and is associated with a significant risk of cardiovascular-renal disease in later life, compared to those born with a typical nephron endowment. The long-term goal of the current proposal is to identify cellular mechanisms that drive successful nephron differentiation to achieve optimal nephron endowment. Specifically, we will explore the roles of the homeobox gene sine oculis 2 (six2), and determine whether six2 is involved in the establishment of nephron number during kidney organogenesis. Using an RNAi methodology, experiments are designed to determine whether inactivation of six2 transcription early in nephrogenesis results in a significant decrease in ureteric bud growth and, therefore, nephron number in an organotypic kidney explant culture. Further, using a mouse model of heritable renal hypoplasia that lacks sufficient expression of six2 during development (the Brachyrrhine (Br) mutant mouse), we will take a systematic approach to re-introduce six2 to kidney explants that are prepared from Br mice and determine if exogenous six2 stimulates branching of the ureteric buds leading to an enhanced nephron production. This proposal will take advantage of the Br mouse strain that displays haploinsufficiency of six2 gene expression and is the only working colony in the world. Taken together, these experiments will provide the fundamental insights that constitute the genetic basis of six2 in renal morphogenesis and specifically establish whether six2 directly determines nephron endowment in the developing kidney. Results from this study will also underscore the importance of six2 in possible nephron restoration approaches in the adult diseased kidney. RELEVANCE: The proposed research is oriented toward a significant translational topic, namely the establishment of nephron number in the developing kidney that pertains specifically to cardiovascular disease and chronic renal failure. Specifically, the current study is aimed at identifying morphogenetic mechanisms that drive successful nephron differentiation to achieve optimal nephron number in the developing kidney.

News
02 February 2018:
The Mary Kay Foundation - GRANT APPLICATION ANNOUNCEMENT

The Mary Kay Foundation

GRANT APPLICATION ANNOUNCEMENT

Applications are accepted from
November 2, 2017 through February 2, 2018

DEADLINE is …

08 December 2017:
F31 Award Submission Alert

The Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (F31 …

06 November 2017:
NRMN Grant Writing Coaching Group Applications

Are you preparing a proposal to submit to NIH in the upcoming months? Do you want to be coached on effective writing techniques from experienced grant…


View more news...


Seminars & Events
16 June 2017, 9am - 10:30am:
HEALTH & MEDICINE SEMINAR - Kukulu Ola Hou
02 June 2017, 8:15am - 4:10pm:
PROMOTING EXCELLENCE IN CLINICAL RESEARCH
02 November 2016, 9am:
RMATRIX-II Collaboration Pilot Projects Program 2017 -- Informational Webinar

View more seminars & events...

Supported by a grant from the National Institute on Minority Health and Health Disparities (U54MD007584), National Institutes of Health.